Limit search to available items
Book Cover

Title Alzheimer's diagnostic guideline validation : exploration of next steps : workshop summary / Diana E. Pankevich, Theresa Wizemann, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Published Washington, D.C. : National Academies Press, [2012]
Online access available from:
ProQuest Ebook Central Subscription Collection    View Resource Record  


Description 1 online resource (PDF file (various pagings)) : illustrations
Contents Background -- Comparing the guidelines -- Validating the new diagnostic guidelines: lessons learned from cardiovascular disease and cholesterol -- Moving forward: validation of the new diagnostic guidelines
Summary At the request of the Alzheimer's Association, the Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders planned and hosted a 2-hour public workshop at the 2011 Alzheimer's Association International Conference (AAIC). Held in Paris, France, on July 18, 2011, the session brought together key stakeholders to discuss next steps in the validation of the new diagnostic guidelines for Alzheimer's disease (AD), specifically, the revised guidelines recently proposed in papers by the International Working Group for New Research Criteria for the Diagnosis of Alzheimer's Disease, and three working groups under the auspices of the National Institute on Aging (NIA) and the Alzheimer's Association
Bibliography Includes bibliographical references
Notes This project was supported by contracts between the National Academy of Sciences and the Alzheimer's Association; AstraZeneca Pharmaceuticals, Inc.; CeNeRx Biopharma; the Department of Health and Human Services' National Institutes of Health (NIH, Contract No. N01-OD-4-2139) through the National Institute of Mental Health, National Institute of Neurological Disorders and Stroke; National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and National Eye Institute, NIH Blueprint for Neuroscience Research, Eli Lilly and Company; GE Healthcare, Inc.; GlaxoSmithKline, Inc.; Johnson & Johnson Pharmaceutical Research and Development, LLC; Merck Research Laboratories; the National Multiple Sclerosis Society; the National Science Foundation (Contract No. OIA-0753701); the Society for Neuroscience; and Wyeth Research, Inc
Online resource; title from PDF cover (viewed June 22, 2012)
Subject Alzheimer's disease -- Diagnosis -- Congresses.
Diagnosis -- Standards -- Congresses.
Alzheimer Disease -- diagnosis.
Practice Guidelines as Topic -- standards.
Genre/Form Congress.
Technical reports.
Conference papers and proceedings.
Form Electronic book
Author Altevogt, Bruce M.
Pankevich, Diana E., 1975-
Wizemann, Theresa M.
Alzheimer's Association. International Conference (2011 : Paris, France)
Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders.
ISBN 030922554X